Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?

Clinical Cancer Research

Volumn 3, Issue 12 I, 1997, Pages 2451-2458

  Dosquet, Christine ^a   Coudert, Marie Claude ^a   Lepage, Eric ^b   Cabane, Jean ^c   Richard, François ^d  

^a SAINT LOUIS HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY CARCINOMA; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN DETERMINATION; SURVIVAL RATE; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; CARCINOMA, RENAL CELL; CELL ADHESION MOLECULES; CYTOKINES; E-SELECTIN; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE VALUES; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031409282     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Stromeyer, T., and Ackermann, R. Classic and modern prognostic indicators in renal cell carcinoma. Review of the literature. Urol. Int., 47: 203-212, 1991.
2. Folkman, J. Clinical applications of research on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995.
3. Weidner, N. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol., 147: 9-19, 1995.
4. Yoshino, S., Kato, M., and Okada, K. Prognostic significance of microvessel count in low stage renal cell carcinoma. Int. J. Urol., 2: 156-160, 1995.
5. MacLennan, G. T., and Bostwick, D. G. Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology, 46: 27-30, 1995.
6. Hahanan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
7. Egushi, J., Nomata, K., Kanda, S., Igawa, T., Taide, M., Koga, S., Matsuya, F., Kanetake, H., and Saito, Y. Gene expression and immunohistochemical localization of basic fibroblast growth factor in renal cell carcinoma. Biochem. Biophys. Res. Commun., 183: 937-944, 1992.
8. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H. F., and Senger, D. R. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol., 143: 1255-1262, 1993.
9. Takahashi, A., Sasaki, H., Kim, S. J., Tobisu, K. I., Kakizoe, T., Tsukamoto, T., Kumamoto, Y., Sugimura, T., and Terada, M. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res., 54: 4233-4237, 1994.
10. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., and Folkman, J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst. (Bethesda), 86: 356-361, 1994.
11. Yamamoto, Y., Toi, M., Kondo, S., Matsumoto, T., Suzuki, H., Kitamura, M., Tsuruta, K., Taniguchi, T., Okamoto, A., Mori, T., Yoshida, M., Ikeda, T., and Tominaga, T. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin. Cancer Res., 2: 821-826, 1996.
12. Fujimoto, K., Ichimori, Y., Kakizoe, T., Okajima, E., Sakamoto, H., Sugimura, T., and Terada, M. Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem. Biophys. Res. Commun., 180: 386-392, 1991.
13. Fujimoto, K., Ichimori, Y., Yamaguchi, H., Arai, K., Futami, T., Ozono, S., Hirao, Y., Kakizoe, T., Terada, M., and Okajima, E. Basic fibroblast growth factor as a candidate tumor marker for renal cell carcinoma. Jpn. J. Cancer Res., 86: 182-186, 1995.
14. Duensing, S., Grosse, J., and Atzpodien, J. Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patients. Anticancer Res., 15: 2331-2334, 1995.
15. Bussolino, F., Di Renzo, M. F., Ziehe, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnoue, L., Coffer, A., and Comoglio, P. M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol., 119: 629-641, 1992.
16. Tashiro, K., Hagiya, M., Nishizawa, T., Seki, T., Shimonishi, M., Shimizu, S., and Nakamura, T. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc. Natl. Acad. Sci. USA, 87: 3200-3204, 1990.
17. Igawa, T., Kanda, S., Kanetake, H., Saitoh, Y., Ichihara, A., Tomita, Y., and Nakamura, T. Hepatocyte growth factor is a potent mitogen for cultured rabbit renal epithelial cells. Biochem. Biophys. Res. Commun., 174: 831-838, 1991.
18. Bichler, K. H., Kleinknecht, S., and Strohmeier, W. L. Immune status and immune therapy of renal cell carcinoma. Urol. Int., 45: 269-283, 1990.
19. Blay, J-Y., Favrot, M., Négrier, S., Combaret, V., Chouaib, S., Mercatello, A., Kaemmerlen, P., Franks, C. R., and Phillip, T. Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factor. Cancer Res., 50: 2371-2374, 1990.
20. Stadler, W. M., Richards, J. M., and Vogelzang, N. J. Serum interleukin-6 levels in metastatic renal cell cancer: correlation with survival but not an independent prognostic indicator. J. Natl. Cancer Inst. (Bethesda), 84: 1835-1836, 1992.
21. Blay, J-Y., Négrier, S., Combaret, V., Attali, S., Goillot, E., Merrouche, Y., Mercatello, A., Ravault, A., Tourani, J-M., Moskovtchenko, J-F., Philip, T., and Favrot, M. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res., 52: 3317-3322, 1992.
22. Dosquet, C., Schaetz, A., Faucher, C., Lepage, E., Wautier, J-L., Richard, F., and Cabane, J. Tumour necrosis factor-α, interleukin-1β and interleukin-6 in patients with renal cell carcinoma. Eur. J. Cancer, 30A: 162-167, 1994.
23. Blay, J-Y., Schemann, S., and Favrot, M. Local production of interleukin-6 by renal adenocarcinoma in vivo. J. Natl. Cancer Inst. (Bethesda), 86: 238-239, 1994.
24. Miki, S., Iwano, M., Miki, Y., Yamamoto, M., Tang, B., Yokokawa, K., Sonoda, T., Hirano, T., and Kishimoto, T. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinoma. FEBS Lett., 250: 607-610, 1989.
25. Gogusev, J., Augusti, M., Chrétien, Y., and Droz, D. Interleukin-6 and TNF-α production in human renal cell carcinoma. Kidney Int., 44: 585-592, 1993.
26. Waase, I., Bergholz, M., Iglauer, A., Beissert, S., Blech, M., Schauer, A., and Krönke, M. Heterogeneity of tumor necrosis factor production in renal cell carcinoma. Eur. J. Cancer, 28A: 1660-1664, 1992.
27. Albelda, S. M. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest., 68: 4-17, 1993.
28. Bevilacqua, M. P. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol., 11: 767-804, 1993.
29. Zocchi, M. R., and Poggi, A. Lymphocyte-endothelial cell adhesion molecules of the primary tumor site in human lung and renal cell carcinoma. J. Natl. Cancer Inst. (Bethesda), 85: 246-247, 1993.
30. Droz, D., Patey, N., Paraf, F., Chrétien, Y., and Gogusev, J. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell carcinomas. Lab. Invest., 71: 710-718, 1994.
31. Griffioen, A. W., Damen, C. A., Martinotti, S., Blijham, G. H., and Groenowegen, G. Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. Cancer Res., 56: 1111-1117, 1996.
32. Steinbach, F., Tanabe, K., Alexander, J., Edinger, M., Tubbs, R., Brenner, W., Stôckle, M., Novick, A. C., and Klein, E. A. The influence of cytokines on the adhesion of renal cancer cells to endothelium. J. Urol., 155: 743-748, 1996.
33. Pigott, R., Dillon, L. P., Hemingway, I. H., Gearing, A. J. H. Soluble forms of E-selectin, ICAM-1. and VCAM-1 are present in the supernatants of cytokine-activated endothelial cells. Biochem. Biophys. Res. Commun., 187: 584-589, 1992.
34. Gearing, A. J. H., and Newman, W. Circulating adhesion molecules in disease. Immunol. Today, 14: 506-512, 1993.
35. Banks, R. E., Gearing, A. J. H., Hemingway, I. K., Norfolk, D. R., Perren, T. J., and Selby, P. J. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br. J. Cancer, 68: 122-124, 1993.
36. Blann, A. D., Daly, R. J., and Amiral, J. The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br. J. Haematol., 92: 498-500, 1996.
37. Sackett, D. L., Haynes, R. B., Guyatt, G. Y., and Tugwell, P. The interpretation of diagnostic data. In: D. L. Sackett, R. B. Haynes, G. Y. Guyatt, and P. Tugwell (eds.). Clinical Epidemiology. A Basic Science for Clinical Medicine, pp. 69-152. Boston: Little, Brown, 1991.
38. Singh, R. K., Bucana, C. D., Gutman, M., Fan, D., Wilson, M. R. M., and Fidler, I. J. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma. Am. J. Pathol., 145: 365-374, 1994.
39. Miyake, H., Hara, I., Yoshimura, K., Eto, H., Arakawa, S., Wada, S., Chihara, K., and Kamidono, S. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential. Cancer Res., 56: 2440-2445, 1996.
40. Nanus, D. M., Schmitz-Dräger, B. J., Motzer, R. J., Lee, A. C., Vlamis, V., Cordon-Cardo, C., Albino, A. P., and Reuter, V. E. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J. Natl. Cancer Inst. (Bethesda), 85: 1597-1599, 1993.
41. Anastassiou, G., Duensing, S., Steinhoff, G., Zorn, U., Grosse, J., Dallman, I., Kirchner, H., Ganser, A., and Atzpodien, J. Platelet endothelial cell adhesion molecule-1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinoma. Oncology (Basel), 53: 127-132, 1996.
42. Muraki, J., Kobayashi, M., Sugaya, Y., Hashimoto, S., Morita, T., Kobayashi, Y., and Tokue, A. Role of serum E-selectin (ELAM-1) and inflammatory parameters in patients with renal cell carcinoma. Jpn. J. Urol., 87: 831-841, 1996.
43. Koch, A. E., Halloran, M. M., Haskell, C. J., Shah, M. R., and Polverini, P. J. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature (Lond.), 376: 517-519, 1995.
44. Tsujisaki, M., Imai, K., Hirata, H., Hanzawa, Y., Masuya, J., Nakano, T., Sugiyama, T., Matsui, M., Hinoda, Y., and Yachi, A. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin. Exp. Immunol., 85: 3-8, 1991.
45. Heicappell, R., Podlinski, J., Buszello, H., and Ackermann, R. Cell surface expression and serum levels of intercellular adhesion molecule-1 in renal cell carcinoma. Urol. Res., 22: 9-15, 1994.
46. Santarosa, M., Favaro, D., Quaia, M., Spada, A., Sacco, C., Talamini, R., and Galligioni, E. Expression and release of intercellular adhesion molecule-1 in renal-cancer patients. Int. J. Cancer, 62: 271-275, 1995.
47. Tomita, Y., Nishiyama, T., Watanabe, H., Fujiwara, M., and Sato, S. Expression of intercellular adhesion molecule-1 (ICAM-1) on renal-cell cancer: possible significance in host immune responses. Int. J. Cancer, 46: 1001-1006, 1990.